Results for tag: "Olysio"

Olysio (simeprevir) is a prescription medication used to treat chronic hepatitis C virus (HCV) infection. It is a protease inhibitor, which works by blocking the action of a specific enzyme that is needed for the virus to replicate. Olysio is used in combination with other medications, such as peginterferon alfa and ribavirin, to treat HCV infection in adults. It is also used in combination with sofosbuvir to treat HCV infection in adults without cirrhosis. Olysio is part of a larger market of infectious diseases drugs, which are used to treat a variety of bacterial, viral, and fungal infections. These drugs are used to treat a wide range of conditions, from common colds to more serious illnesses such as HIV/AIDS and tuberculosis. The market for infectious diseases drugs is highly competitive, with many companies offering a variety of treatments. Some of the companies in the Olysio market include Johnson & Johnson, Gilead Sciences, Merck & Co., Bristol-Myers Squibb, and AbbVie. Show Less Read more